Evidence map›Paper›PMID 24675165›Full record

ArticleDiagnostic and interventional radiology (Ankara, Turkey)

Angioplasty for pediatric renovascular hypertension: a 13-year experience.

Guangchang Zhu, Fuliang He, Yongquan Gu, Hengxi Yu, Bing Chen, Zhiwei Hu, Weitao Liang, Zhonggao Wang

Registry-linked trialOpen access · greenAbstract readEvaluation Study
In one paragraph

Article in Diagnostic and interventional radiology (Ankara, Turkey). The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04137614 (The Effects and Safety of Drug-coated Balloon in the Treatment of Hypertension Caused by Takayasu Arteritis Associated Renal Artery Stenosis), which is not on this map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04137614 naunknown statusnot on this map

The Effects and Safety of Drug-coated Balloon in the Treatment of Hypertension Caused by Takayasu Arteritis Associated Renal Artery Stenosis: a Single Centre, Random, Double Blind Trial

TypeinterventionalSponsorShanghai Zhongshan HospitalRan2019 to 2022Enrolled30ConditionsTakayasu ArteritisArmsDrug coated balloon (DCB), Digital substraction angiography (DSA)
3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 67 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Endovascular salvage of renal artery bypass in pediatric a patient with neurofibromatosis type 1.Journal of vascular surgery cases and innovative techniques · 2025
    Article
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Childhood-onset Takayasu Arteritis.European journal of rheumatology · 2020
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Guangchang ZhuFrom the Department of Vascular Surgery Second Artillery General Hospital, Beijing Normal University, Beijing, China. zhonggaowang@yeah.net.
Fuliang He
Yongquan Gu
Hengxi Yu
Bing Chen
Zhiwei Hu
Weitao Liang
Zhonggao Wang
University Radiology · USBeijing Normal University · CNCapital Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeWe aimed to evaluate the long-term outcome and efficacy of percutaneous transluminal renal angioplasty (PTRA) for pediatric renal artery stenosis (RAS), which is an important cause of medication-refractory pediatric hypertension. MATERIALS AND

methodsWe retrospectively evaluated 22 hypertensive children (age range, 3-17 years) who underwent PTRA from February 2000 to July 2012. Sixteen patients had Takayasu arteritis and six fibromuscular dysplasia. Five were not included in the statistical analysis due to loss to follow-up.

resultsTechnical success was achieved in 32 of 34 procedures (94.1%). The stenosis rate decreased from 84.5% before PTRA to 20.1% after PTRA. Treatment was effective in 72.7% (16/22) of patients, including complete cure in 27.3% (6/22) and improvement in 45.5% (10/22). Systolic and diastolic blood pressures decreased from 153 ± 19.1 to 131.7 ± 21.4 mmHg and from 97.9 ± 14.2 to 83.6 ± 19.3 mmHg, respectively (P <0.01). Number of antihypertensive agents decreased from 2.7 to 0.5 per patient. Restenosis was detected in 40.9% (9/22) of patients, with a restenotic interval of 11.8 months (range, 3-47 months). Lesion length was strongly correlated with clinical success (cure and improvement) (independent-sample t test, P <0.001; binary logistic regression, P = 0.040).

conclusionLesion length is an important determination of clinical success with PTRA for pediatric RAS. PTRA is an appropriate treatment option for pediatric renovascular hypertension due to Takayasu arteritis and fibromuscular dysplasia.

Indexed as

Angioplasty, BalloonAdolescentAntihypertensive AgentsBlood PressureChildChild, PreschoolFemaleHumansHypertension, RenovascularKidney DiseasesLongitudinal StudiesMaleRadiographyRenal Artery ObstructionRetrospective StudiesTreatment OutcomeAntihypertensive Agents

Identifiers

PMID24675165
PMCPMC4463347
OpenAlexW2128477822

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.